Eimear Kenny, PhD, is the Founding Director of the Institute for Genomic Health, building resources for integrating genomic information and AI in routine clinical care, and supporting the sequencing and return of results to a diverse patients in the Mount Sinai Health System. She also the Founding Director of the Center for Translational Genomics and a Professor of Medicine and Genetics, at the Icahn School of Medicine at Mount Sinai, working on computational and translational genomic research. She is Principal Investigator in many large NIH-funded international consortium focused on computational genomics and genomic medicine, including eMERGE, PRIMED, CSER, GSP, TOPMed, PAGE, and HPRC. She is a strong advocate for the importance of
diversity in genomic research, is improving the accessibility of genetics to global populations, and has led multiple genetics-based clinical trials. Her exceptional contributions to the field earned her the prestigious Early Career Award from the American Society of Human Genetics in 2022. In addition to her academic and research roles, Dr. Kenny serves as a scientific advisor to various genomic medicine initiatives in government, non-profit, and industry sectors.